MENUCLOSE

 

Connect with us

News

ArcheMedX Releases New Oncology Findings Ahead Of ESMO Congress Revealing Clinician Readiness

2021 was a historic year in the battle to defeat cancer.   More novel cancer treatments became available than ever before with the number of Oncology specific clinical trials also reaching an all-time high, up 56% from 2016 and mostly focused on rare cancer indications. With global spending on Oncology expected to exceed $300

ArcheMedX Achieves Data Milestone Modeling Over 25 Million Learning Behaviors

ArcheMedX, a behavioral science-based learning company providing a smarter way to predict and improve clinical team performance, recently passed a significant data milestone. PRWeb - Charlottesville, VA March 24, 2022 Today, the Company announced its clinician learning and predictive analytics platform, Ready, has now surpassed more than 25 million essential learning behaviors
Continue Reading

AMA Recognizes ArcheMedX’s COVID-19 Report on Virtual Tech in Clinical Trials for Excellence

Today, ArcheMedX announced that its 2020 industry report, “COVID-19's Impact on Virtual Tech in Clinical Trials, was honored with a prestigious American Marketing Association (AMA) award. Every year, the AMA honors hundreds of stand-out marketers through awards programs presented by the AMA Foundation, local professional chapters, and academic special interest groups.
Continue Reading